Verrica Pharmaceuticals Inc. (VRCA) Gross margin 2023–2024
Verrica Pharmaceuticals Inc. (VRCA) gross margin by fiscal year — reported gross profit divided by reported revenue.
65.6%FY2024 · since FY2023: 90.2% → 65.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 65.6% | -24.6 pp |
| FY2023 | 90.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice